The psychology of chronic obstructive pulmonary disease

Current Opinion in Psychiatry

Volumn 26, Issue 5, 2013, Pages 458-463

  Von Leupoldt, Andreas ^a,b   Kenn, Klaus ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Allergology and Sleep Medicine   (Germany)

Author keywords

Anxiety; COPD; Depression; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE;

ANXIETY DISORDER; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEPRESSION; DISEASE COURSE; DYSPNEA; ECONOMIC ASPECT; EMOTION; EXERCISE; FEAR; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LEISURE; LIFE SUSTAINING TREATMENT; LUNG FUNCTION; META ANALYSIS (TOPIC); MORTALITY; OXYGEN THERAPY; PROBLEM SOLVING; PSYCHOLOGICAL ASPECT; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SELF CONCEPT; SOCIAL ISOLATION; SOCIAL PARTICIPATION; SOCIAL SUPPORT; STRESS MANAGEMENT; SUICIDAL IDEATION; SUICIDE ATTEMPT;

ANTIDEPRESSIVE AGENTS; ANXIETY; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84881374960     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328363c1fc     Document Type: Review

References (51)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD. 2011. http://www.goldcopd.com. [Accessed 9 September 2012]
2. Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet 2011; 378: 991-996.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442.
4. Kaptein AA, Scharloo M, Fischer MJ, et al. 50 years of psychological research on patients with COPD: road to ruin or highway to heaven? Respir Med 2009; 103: 3-11.
5. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134:43S-56S.
6. Von Leupoldt A, Fritzsche A, Trueba AF, et al. Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med 2012; 44: 52-65.
7. Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol 2000; 10: 193-202. (Pubitemid 30598979)
8. Zhang MWB, Ho RCM, Cheung MWL, et al. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry 2011; 33: 217-223.
9. Hanania NA, Müllerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011; 183: 604-611.
10. Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 2012; 12:53.
11. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD 2011; 8: 293-299.
12. Burgel P-R, Escamilla R, Perez T, et al. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med 2013; 107:233- 241.
13. Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and metaanalysis of Pearson correlations. Prim Care Respir J 2011; 20: 257-268.
14. Khdour MR, Hawwa AF, Kidney JC, et al. Potential risk factors for medication nonadherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol 2012; 68: 1365-1373.
15. De Voogd JN, Sanderman R, Postema K, et al. Relationship between anxiety and dyspnea on exertion in patients with chronic obstructive pulmonary disease. Anxiety Stress Coping 2011; 24: 439-449.
16. Oga T, Tsukino M, Hajiro T, et al. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res 2012; 13:85.
17. Papaioannou AI, Bartziokas K, Tsikrika S, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J 2013; 41: 815-823.
18. Von Leupoldt A, Taube K, Lehmann K, et al. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 2011; 140: 730-736.
19. Coventry PA, Gemmell I, Todd CJ. Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study. BMC Pulm Med 2011; 11:49.
20. Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 2012; 185: 918-923.
21. Janssen DJA, Spruit MA, Schols JMGA, et al. Predicting changes in preferences for life-sustaining treatment among patients with advanced chronic organ failure. Chest 2012; 141: 1251-1259.
22. Abrams TE, Vaughan-Sarrazin M, Van der Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics 2011; 52: 441-449.
23. Divo M, Cote C, De Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 155-161.
24. Goodwin RD. Is COPD associated with suicide behavior? J Psychiatr Res 2011; 45: 1269-1271.
25. Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest 2010; 137: 341-347.
26. Goodwin RD, Lavoie KL, Lemeshow AR, et al. Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res 2012; 14: 176-183.
27. Al-shair K, Kolsum U, Dockry R, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011; 12:3.
28. Tetikkurt C, Ozdemir I, Tetikkurt S, et al. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Respir Med 2011; 6: 226-231.
29. Thomsen M, Dahl M, Lange P, et al. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 982-988.
30. Dodd JW, Chung AW, Van den Broek MD, et al. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med 2012; 186:240- 245.
31. Von Leupoldt A, Brassen S, Baumann HJ, et al. Structural brain changes related to disease duration in patients with asthma. PLoS ONE 2011; 6:e23739.
32. Livermore N, Sharpe L, McKenzie D. Catastrophic interpretations and anxiety sensitivity as predictors of panic-spectrum psychopathology in chronic obstructive pulmonary disease. J Psychosom Res 2012; 72: 388-392.
33. Fritzsche A, Watz H, Magnussen H, et al. Cognitive biases in patients with chronic obstructive pulmonary disease and depression: a pilot study. Brit J Health Psychol 2013. [Epub ahead of print]; doi: 10.1111/bjhp.12025.
34. Naberan K, Azpeitia A, Cantoni J, Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med 2012; 106: 367-373.
35. Lu Y, Nyunt MSZ, Gwee X, et al. Life event stress and chronic obstructive pulmonary disease (COPD): associations with mental well being and quality of life in a population-based study. BMJ Open 2012; 2.
36. Fischer MJ, Scharloo M, Abbink J, et al. Concerns about exercise are related to walk test results in pulmonary rehabilitation for patients with COPD. Int J Behav Med 2012; 19: 39-47.
37. Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest 2011; 140: 618-625.
38. Kühl K, Kuhn C, Kenn K, Rief W. The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients. Psychother Psychosom Med Psychol 2011; 61:e1-e9.
39. Stenzel N, Rief W, Kühl K, et al. Fear of progression and end-of-life fear in COPD patients (in German). Pneumologie 2012; 66: 111-118.
40. Zöckler N, Rief W, Kühl K, Kenn K. COPD-specific anxiety and depressive symptoms in COPD patients (in German). Pneumologie 2012; 66: 290-296.
41. Fritzsche A, Clamor A, Von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD: a review. Respir Med 2011; 105: 1422-1433.
42. Usmani ZA, Carson KV, Cheng JN, et al. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011; CD008483.
43. Yohannes AM, Connolly MJ. Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression? Expert Rev Respir Med 2011; 5: 727-729.
44. Jiang X, He G. Effects of an uncertainty management intervention on uncertainty, anxiety, depression, and quality of life of chronic obstructive pulmonary disease outpatients. Res Nurs Health 2012; 35: 409-418.
45. Jonkers CCM, Lamers F, Bosma H, et al. The effectiveness of a minimal psychological intervention on self-management beliefs and behaviors in depressed chronically ill elderly persons: a randomized trial. Int Psychogeriatr 2012; 24: 288-297.
46. Harrison SL, Greening NJ, Williams JEA, et al. Have we underestimated the efficacy of pulmonary rehabilitation in improving mood? Respir Med 2012; 106: 838-844.
47. Bratås O, Espnes GA, Rannestad T, Walstad R. Relapse of health related quality of life and psychological health in patients with chronic obstructive pulmonary disease 6 months after rehabilitation. Scand J Caring Sci 2012; 26: 219-227.
48. Trivedi RB, Bryson CL, Udris E, Au DH. The influence of informal caregivers on adherence in COPD patients. Ann Behav Med 2012; 44: 66-72.
49. Petersen S, Taube K, Lehmann K, et al. Social comparison and anxious mood in pulmonary rehabilitation: the role of cognitive focus. Br J Health Psychol 2012; 17: 463-476.
50. Bonsaksen T, Lerdal A, Fagermoen MS. Factors associated with self-efficacy in persons with chronic illness. Scand J Psychol 2012; 53: 333-339.
51. Kaptein AA, Scharloo M, Fischer MJ, et al. Illness perceptions and COPD: an emerging field for COPD patient management. J Asthma 2008; 45: 625-629.